Biotech Cidara Therapeutics and Melinta Therapeutics Announce Publication of Data from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in The Lancet November 28, 2022
Biotech ContraFect Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections November 28, 2022
Biotech Galectin Therapeutics to Present at 6th Obesity & NASH Drug Development Summit November 28, 2022
Biotech Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis November 28, 2022
Biotech Anavex Life Sciences Reports Fiscal 2022 Year End Financial Results and Provides Business Update November 28, 2022
Biotech Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options November 27, 2022
Health Brooklyn Immuno Therapeutics Releases Information on Irx-2 Phase 2 Head and Neck Cancer Study Findings July 27, 2022
Biotech Evofem Biosciences Unveils New Educational Birth Control Chart to Assist Providers in Patient Contraceptive Counseling July 25, 2022
Search
